The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Genome (DNA) Sequencing Market Research Report 2024

Global Genome (DNA) Sequencing Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1764681

No of Pages : 90

Ask Your Query

Synopsis
Genome (DNA) sequencing is a method that allows several DNA strands to be sequenced simultaneously. Genome sequencing technology aids in the sequencing of an organism's whole genome in order to determine the order or sequence of DNA nucleotides or bases coded with letters including As, Gs, Cs, and Ts. Genome sequencing methods made it feasible to investigate genetics, biomarkers, forensics, customized medicine, and other fields. This technology aids in the transition from traditional procedures to customized medications with the use of genetics. It is a widely utilized method for whole-genome sequencing.

Global Genome (DNA) Sequencing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Genome (DNA) Sequencing market research.

Key companies engaged in the Genome (DNA) Sequencing industry include Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen and Oxford Nanopore Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Genome (DNA) Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Genome (DNA) Sequencing market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Genome (DNA) Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Agilent Technologies Inc.
  • BGI
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Genome Electric Company
  • Illumina Inc.
  • IntegraGen
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • QIAGEN
  • Thermo Fisher Scientific Inc.

Segment by Type

  • Next-Generation Sequencing
  • Third Generation DNA Sequencing
  • Others

Segment by Application

  • Research Institutes
  • Pharmaceutical & Biotechnological Companies
  • Healthcare Facilities & Diagnostic Centres

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Genome (DNA) Sequencing report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome (DNA) Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Next-Generation Sequencing
1.2.3 Third Generation DNA Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Genome (DNA) Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Research Institutes
1.3.3 Pharmaceutical & Biotechnological Companies
1.3.4 Healthcare Facilities & Diagnostic Centres
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome (DNA) Sequencing Market Perspective (2018-2029)
2.2 Genome (DNA) Sequencing Growth Trends by Region
2.2.1 Global Genome (DNA) Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genome (DNA) Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Genome (DNA) Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Genome (DNA) Sequencing Market Dynamics
2.3.1 Genome (DNA) Sequencing Industry Trends
2.3.2 Genome (DNA) Sequencing Market Drivers
2.3.3 Genome (DNA) Sequencing Market Challenges
2.3.4 Genome (DNA) Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome (DNA) Sequencing Players by Revenue
3.1.1 Global Top Genome (DNA) Sequencing Players by Revenue (2018-2023)
3.1.2 Global Genome (DNA) Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Genome (DNA) Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome (DNA) Sequencing Revenue
3.4 Global Genome (DNA) Sequencing Market Concentration Ratio
3.4.1 Global Genome (DNA) Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome (DNA) Sequencing Revenue in 2022
3.5 Genome (DNA) Sequencing Key Players Head office and Area Served
3.6 Key Players Genome (DNA) Sequencing Product Solution and Service
3.7 Date of Enter into Genome (DNA) Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome (DNA) Sequencing Breakdown Data by Type
4.1 Global Genome (DNA) Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Genome (DNA) Sequencing Forecasted Market Size by Type (2024-2029)
5 Genome (DNA) Sequencing Breakdown Data by Application
5.1 Global Genome (DNA) Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Genome (DNA) Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genome (DNA) Sequencing Market Size (2018-2029)
6.2 North America Genome (DNA) Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genome (DNA) Sequencing Market Size by Country (2018-2023)
6.4 North America Genome (DNA) Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome (DNA) Sequencing Market Size (2018-2029)
7.2 Europe Genome (DNA) Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genome (DNA) Sequencing Market Size by Country (2018-2023)
7.4 Europe Genome (DNA) Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome (DNA) Sequencing Market Size (2018-2029)
8.2 Asia-Pacific Genome (DNA) Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genome (DNA) Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Genome (DNA) Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome (DNA) Sequencing Market Size (2018-2029)
9.2 Latin America Genome (DNA) Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genome (DNA) Sequencing Market Size by Country (2018-2023)
9.4 Latin America Genome (DNA) Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome (DNA) Sequencing Market Size (2018-2029)
10.2 Middle East & Africa Genome (DNA) Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genome (DNA) Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Genome (DNA) Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies Inc.
11.1.1 Agilent Technologies Inc. Company Detail
11.1.2 Agilent Technologies Inc. Business Overview
11.1.3 Agilent Technologies Inc. Genome (DNA) Sequencing Introduction
11.1.4 Agilent Technologies Inc. Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.1.5 Agilent Technologies Inc. Recent Development
11.2 BGI
11.2.1 BGI Company Detail
11.2.2 BGI Business Overview
11.2.3 BGI Genome (DNA) Sequencing Introduction
11.2.4 BGI Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.2.5 BGI Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Genome (DNA) Sequencing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Genome (DNA) Sequencing Introduction
11.4.4 Danaher Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.4.5 Danaher Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Genome (DNA) Sequencing Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Genome Electric Company
11.6.1 Genome Electric Company Company Detail
11.6.2 Genome Electric Company Business Overview
11.6.3 Genome Electric Company Genome (DNA) Sequencing Introduction
11.6.4 Genome Electric Company Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.6.5 Genome Electric Company Recent Development
11.7 Illumina Inc.
11.7.1 Illumina Inc. Company Detail
11.7.2 Illumina Inc. Business Overview
11.7.3 Illumina Inc. Genome (DNA) Sequencing Introduction
11.7.4 Illumina Inc. Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.7.5 Illumina Inc. Recent Development
11.8 IntegraGen
11.8.1 IntegraGen Company Detail
11.8.2 IntegraGen Business Overview
11.8.3 IntegraGen Genome (DNA) Sequencing Introduction
11.8.4 IntegraGen Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.8.5 IntegraGen Recent Development
11.9 Oxford Nanopore Technologies
11.9.1 Oxford Nanopore Technologies Company Detail
11.9.2 Oxford Nanopore Technologies Business Overview
11.9.3 Oxford Nanopore Technologies Genome (DNA) Sequencing Introduction
11.9.4 Oxford Nanopore Technologies Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.9.5 Oxford Nanopore Technologies Recent Development
11.10 Pacific Biosciences of California Inc.
11.10.1 Pacific Biosciences of California Inc. Company Detail
11.10.2 Pacific Biosciences of California Inc. Business Overview
11.10.3 Pacific Biosciences of California Inc. Genome (DNA) Sequencing Introduction
11.10.4 Pacific Biosciences of California Inc. Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.10.5 Pacific Biosciences of California Inc. Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Detail
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Genome (DNA) Sequencing Introduction
11.11.4 QIAGEN Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.11.5 QIAGEN Recent Development
11.12 Thermo Fisher Scientific Inc.
11.12.1 Thermo Fisher Scientific Inc. Company Detail
11.12.2 Thermo Fisher Scientific Inc. Business Overview
11.12.3 Thermo Fisher Scientific Inc. Genome (DNA) Sequencing Introduction
11.12.4 Thermo Fisher Scientific Inc. Revenue in Genome (DNA) Sequencing Business (2018-2023)
11.12.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock